Genome-scale gene expression analysis is rapidly changing how we study, diagnose and treat human cancers. In order to meet the scientific needs of Cancer Center investigators for gene expression analyses, the Gene- Expression Shared Facility was established in early 2004. The facility provides support to Cancer Center investigators interested in microarray technology. The facility was recently established using Cancer Center developmental funds and is focused primarily on the study of gene expression analyses as they relate to human malignancy. The facility includes both Affymetrix and spotted array technologies and has incorporated into it a strong bioinformatics network to support the facility. Real-time quantitative PCR analysis has been included in order to provide a rapid method to validate hits from microarray experiments. The Shared Facility has been designed specifically to: 1) provide a comprehensive facility for global-scale gene expression studies with a emphasis on human malignancies; 2) provide a broad range of services in order to meet the scientific needs of a variety of Cancer Center investigators including basic researchers and clinicians; 3) work closely with the Biostatistics and Bioinformatics Shared Facility to provide investigators with experimental design, data analysis and data interpretation support; 4) educate investigators and work to increase knowledge and understanding of microarray technology in order to most appropriately utilize the technologies. The facility provides full support including experimental design, RNA purification, probe synthesis, array hybridizations, data acquisition and storage, and full bioinformatics support. The facility is staffed by two Co-directors, two technical staff and a bioinformatics specialist.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-37
Application #
7587503
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
37
Fiscal Year
2008
Total Cost
$112,544
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Buford, Thomas W; Carter, Christy S; VanDerPol, William J et al. (2018) Composition and richness of the serum microbiome differ by age and link to systemic inflammation. Geroscience 40:257-268
Kim, Harrison (2018) Variability in Quantitative DCE-MRI: Sources and Solutions. J Nat Sci 4:
Frugé, Andrew D; Van der Pol, William; Rogers, Laura Q et al. (2018) Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. J Acad Nutr Diet :
Pruitt, Hawley C; Metge, Brandon J; Weeks, Shannon E et al. (2018) Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors. Oncogene 37:1610-1623
Boitano, Teresa K L; Smith, Haller J; Rushton, Tullia et al. (2018) Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol 151:282-286
Jo, SeongHo; Chen, Junqin; Xu, Guanlan et al. (2018) miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 67:256-264
Frugé, Andrew D; Ptacek, Travis; Tsuruta, Yuko et al. (2018) Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy. J Acad Nutr Diet 118:714-723.e1
Crenshaw, Brennetta J; Gu, Linlin; Sims, Brian et al. (2018) Exosome Biogenesis and Biological Function in Response to Viral Infections. Open Virol J 12:134-148
Si, Ying; Cui, Xianqin; Crossman, David K et al. (2018) Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol Dis 114:85-94
Sahay, Bikash; Bashant, Kathleen; Nelson, Nicole L J et al. (2018) Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling. Infect Immun 86:

Showing the most recent 10 out of 747 publications